Skip to main content

Table 11 Sensitivity analysis, selective analysis for the five studies meeting the inclusion criteria

From: Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer

  Studies Measure Region Value set N Mean 95% CI Weight (%) Estimate [95% CI] I2(%)
1 Studies conducted in China, using EQ5D5L, valued by same China dataset (Luo 2017)
Li 2019 EQ-5D-5L China China EQ5D5L, Luo 2017 608 0.83 0.81, 0.84 51 0.84
[0.81, 0.87]
85
Yang 2020 EQ-5D-5L China China EQ5D5L, Luo 2017 446 0.86 0.84, 0.87 48
2 Studies using EQ5D5L in China
  Li 2019 EQ-5D-5L China China EQ5D5L, Luo 2017 608 0.83 0.81, 0.84 33 0.82
[0.77, 0.87]
97
  Yang 2020 EQ-5D-5L China China EQ5D5L, Luo 2017 446 0.86 0.84, 0.87 32  
  Wang 2018 EQ-5D-3L China China EQ5D3L, Liu 2014 2626 0.78 0.77, 0.78 34  
3 Studies using EQ5D5L, valued by same China dataset (Luo 2017)
Li 2019 EQ-5D-5L China China EQ5D5L, Luo 2017 608 0.83 0.81, 0.84 33 0.87
[0.81, 0.92]
97
Yang 2020 EQ-5D-5L China China EQ5D5L, Luo 2017 446 0.86 0.84, 0.87 33
Ou 2019 EQ-5D-5L Taiwan China EQ5D5L, Luo 2017 193 0.92 0.90, 0.93 33
4 Studies using EQ5D5L
Li 2019 EQ-5D-5L China China EQ5D5L, Luo 2017 608 0.83 0.81, 0.84 25 0.84
[0.78, 0.90]
98
Yang 2020 EQ-5D-5L China China EQ5D5L, Luo 2017 446 0.86 0.84, 0.87 24
Ou 2019 EQ-5D-5L Taiwan China EQ5D5L, Luo 2017 193 0.92 0.90, 0.93 25
Cheung 2014 EQ-5D-5L Singapore Japanese (Rabin) 238 0.77 0.75, 0.79 24
5 All studies
Li 2019 EQ-5D-5L China China EQ5D5L, Luo 2017 608 0.83 0.81, 0.84 20 0.83
[0.77, 0.89]
99
Yang 2020 EQ-5D-5L China China EQ5D5L, Luo 2017 446 0.86 0.84, 0.87 19
Ou 2019 EQ-5D-5L Taiwan China EQ5D5L, Luo 2017 193 0.92 0.90, 0.93 20
Cheung 2014 EQ-5D-5L Singapore Japanese (Rabin) 238 0.77 0.75, 0.79 19
Wang 2018 EQ-5D-3L China China EQ5D3L, Liu 2014 2626 0.78 0.77, 0.78 20